Synergistic Brain Energy Optimization System
Legal Citation
Summary of the Inventive Concept
A novel system integrating medium-chain triglycerides (MCTs) with AI, IoT, blockchain, and advanced materials to optimize brain energy levels and provide personalized health management.
Background and Problem Solved
The original patent disclosed the use of MCTs for treating brain energy deficiency conditions. However, the patent did not address the need for real-time monitoring, personalized treatment, and secure data storage. The present inventive concept solves these limitations by combining MCTs with cutting-edge technologies to create a comprehensive brain energy optimization system.
Detailed Description of the Inventive Concept
The system comprises a composition of MCTs, an AI-powered brain activity monitor, a blockchain-based data storage and analysis module, and an IoT-enabled communication module. The AI-powered brain activity monitor provides real-time feedback on brain energy levels, enabling personalized treatment with the MCT composition. The blockchain technology ensures secure storage and analysis of brain energy data, while the IoT-enabled communication module enables seamless data transmission to a remote server. Additionally, the system may incorporate a wearable device with a sensor for detecting ketone levels, and a novel material composite of MCTs and graphene-based nanomaterials to enhance bioavailability and brain energy levels.
Novelty and Inventive Step
The integration of MCTs with AI, IoT, blockchain, and advanced materials to create a synergistic system for brain energy optimization is new and non-obvious compared to the original patent. The inventive concept's novelty lies in the unexpected combination of these distinct technologies to provide a comprehensive solution for brain energy management.
Alternative Embodiments and Variations
Alternative embodiments of the system may include the use of different AI algorithms, blockchain platforms, or IoT communication protocols. Variations of the system may also include the incorporation of additional sensors or biomarkers to track brain energy levels, or the use of different materials or composites to enhance MCT bioavailability.
Potential Commercial Applications and Market
The synergistic brain energy optimization system has significant commercial potential in the health and wellness industry, particularly in the areas of personalized medicine, brain health, and cognitive performance. The system may be marketed as a comprehensive solution for individuals seeking to optimize their brain energy levels, and may be targeted towards athletes, professionals, and individuals with brain energy deficiency conditions.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Neurological health technologies, medical device systems, and metabolic intervention strategies with a focus on brain energy management and medium-chain triglyceride (MCT) compositions
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biomedical engineering, neuroscience, or related fields, possessing expertise in metabolic interventions, medical device integration, and AI-driven health monitoring technologies
Obviousness Rationale
A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with MCT compositions represents a predictable extension of existing medical monitoring and intervention strategies. The core MCT composition remains substantially similar to the source patent, with the primary innovation being the technological infrastructure for personalized monitoring and data management. The combination of known technologies to achieve enhanced patient monitoring and treatment optimization would be considered an obvious design choice within the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,527 |
|---|---|
| Title | Medium chain triglyceride compositions |
| Assignee(s) | SOCIÉTÉ DES PRODUITS NESTLÉ S.A. |